Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2008 Sep 8;268(1):10-30.
doi: 10.1016/j.canlet.2008.03.024. Epub 2008 Apr 25.

Nitric oxide as a target of complementary and alternative medicines to prevent and treat inflammation and cancer

Lorne J Hofseth  1
Affiliations
Review

Nitric oxide as a target of complementary and alternative medicines to prevent and treat inflammation and cancer

Lorne J Hofseth. Cancer Lett. .

Abstract

Nitric oxide (NO) and associated reactive nitrogen species (RNS) are involved in many physiological functions. There has been an ongoing debate to whether RNS can inhibit or perpetuate chronic inflammation and associated carcinogenesis. Although the final outcome depends on the genetic make-up of its target, the surrounding microenvironment, the activity and localization of nitric oxide synthase (NOS) isoforms, and overall levels of NO/RNS, evidence is accumulating that in general, RNS drive inflammation and cancers associated with inflammation. To this end, many complementary and alternative medicines (CAMs) that work in chemoprevention associated with chronic inflammation, are inhibitors of excessive NO observed in inflammatory conditions. Here, we review recent literature outlining a role of NO/RNS in chronic inflammation and cancer, and point toward NO as one of several targets for the success of CAMs in treating chronic inflammation and cancer associated with this inflammation.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Popular and powerful CAMs target many key players in inflammation.
See this image and copyright information in PMC

References

    1. Hofseth LJ, Hussain SP, Wogan GN, Harris CC. Nitric oxide in cancer and chemoprevention. Free Radical Biology and Medicine. 2003;34:955–968. - PubMed
    1. Ying L, Hofseth LJ. An emerging role for endothelial nitric oxide synthase in chronic inflammation and cancer. Cancer Res. 2007;67:1407–1410. - PubMed
    1. Lancaster JR, Jr, Xie K. Tumors face NO problems? Cancer Res. 2006;66:6459–6462. - PubMed
    1. Fukumura D, Kashiwagi S, Jain RK. The role of nitric oxide in tumour progression. Nat Rev Cancer. 2006;6:521–534. - PubMed
    1. Hofseth LJ, Ying L. Identifying and defusing weapons of mass inflammation in carcinogenesis. Biochim Biophys Acta. 2006;1765:74–84. Epub 2005 Sep 2008. - PubMed

Publication types